Petrelli F - Search Results

1

Salvage Therapy in Advanced Adult Soft Tissue Sarcoma: A Systematic Review and Meta-Analysis of Randomized Trials.

Comandone A, Petrelli F, Boglione A, Barni S. Comandone A, et al. Among authors: petrelli f. Oncologist. 2017 Dec;22(12):1518-1527. doi: 10.1634/theoncologist.2016-0474. Epub 2017 Aug 23. Oncologist. 2017. PMID: 28835514 Free PMC article. Review.

2

From the trastuzumab era to new target therapies: beyond revolution.

Barni S, Petrelli F, Cabiddu M, Cazzaniga ME, Cremonesi M. Barni S, et al. Among authors: petrelli f. Ann Oncol. 2007 Jun;18 Suppl 6:vi1-4. doi: 10.1093/annonc/mdm214. Ann Oncol. 2007. PMID: 17591799 Review. No abstract available.

3

Targeted therapies for the treatment of breast cancer in the post-trastuzumab era.

Petrelli F, Cabiddu M, Cazzaniga ME, Cremonesi M, Barni S. Petrelli F, et al. Oncologist. 2008 Apr;13(4):373-81. doi: 10.1634/theoncologist.2007-0173. Oncologist. 2008. PMID: 18448551 Review.

4

Toxicity of targeted therapies in elderly patients.

Barni S, Cabiddu M, Petrelli F. Barni S, et al. Among authors: petrelli f. Expert Rev Anticancer Ther. 2008 Dec;8(12):1965-76. doi: 10.1586/14737140.8.12.1965. Expert Rev Anticancer Ther. 2008. PMID: 19046116 Review.

5

Current data of targeted therapies for the treatment of triple-negative advanced breast cancer: empiricism or evidence-based?

Petrelli F, Cabiddu M, Ghilardi M, Barni S. Petrelli F, et al. Expert Opin Investig Drugs. 2009 Oct;18(10):1467-77. doi: 10.1517/13543780903222268. Expert Opin Investig Drugs. 2009. PMID: 19737114 Review.

6

Is there a role for maintenance therapy in non-small-cell lung cancer? An emerging issue.

Petrelli F, Ghilardi M, Cremonesi M, Cabiddu M, Barni S. Petrelli F, et al. Expert Rev Anticancer Ther. 2009 Oct;9(10):1455-65. doi: 10.1586/era.09.112. Expert Rev Anticancer Ther. 2009. PMID: 19828007 Review.

7

Benefit of adjuvant chemotherapy in elderly ER-negative breast cancer patients: benefits and pitfalls.

Barni S, Cabiddu M, Petrelli F. Barni S, et al. Among authors: petrelli f. Expert Rev Anticancer Ther. 2010 Feb;10(2):185-98. doi: 10.1586/era.09.188. Expert Rev Anticancer Ther. 2010. PMID: 20131995 Review.

8

Should adjuvant trastuzumab be offered in very early-stage (pT1a/bN0M0) HER2-neu-positive breast cancer? A current debate.

Petrelli F, Barni S. Petrelli F, et al. Med Oncol. 2011 Jun;28(2):401-8. doi: 10.1007/s12032-010-9460-0. Epub 2010 Mar 2. Med Oncol. 2011. PMID: 20195801 Review.

9

What else in gemcitabine-pretreated advanced pancreatic cancer? An update of second line therapies.

Petrelli F, Borgonovo K, Ghilardi M, Cabiddu M, Barni S. Petrelli F, et al. Rev Recent Clin Trials. 2010 Jan;5(1):43-56. doi: 10.2174/157488710790820553. Rev Recent Clin Trials. 2010. PMID: 20205687 Review.

10

Targeted delivery for breast cancer therapy: the history of nanoparticle-albumin-bound paclitaxel.

Petrelli F, Borgonovo K, Barni S. Petrelli F, et al. Expert Opin Pharmacother. 2010 Jun;11(8):1413-32. doi: 10.1517/14656561003796562. Expert Opin Pharmacother. 2010. PMID: 20446855 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results